Elos Medtech Interim Report January 1 - September 30, 2018
Strategic target of double-digit growth achieved July – September 2018 • Net sales for the quarter increased and amounted to SEK 154.1 million (132.5), corresponding to organic growth of 16.3%. After currency adjustments, growth was 8.9%. • Operating profit amounted to SEK 11.8 million (9.3). Operating margin for the third quarter of 2018 was 7.7%, compared to 7.0% for the same period last year. • Operating profit amounted to SEK 11.8 million (9.3). Operating margin for the third quarter of 2018 was 7.7%, compared to 7.0% for the same period last year. • Profit after